If you have any question, please feel free to email us. We will touch with you as soon as possible.
Bosutinib belongs to a family of medications called protein tyrosine kinase inhibitors. It is used to treat adults with certain types of Philadelphia-positive chronic myelogenous leukemia (Ph+ CML) in blast crisis (sudden attack), accelerated phase (fast growth), or in chronic phase (long-term illness). For R&D purposes only.
* Please be kindly noted products are supplied for RLD supplies/ Reference listed drugs/ Comparator Drug Clinical trials. We do not sell to patients.
| Generic name | Bosutinib Monohydrate Tablets |
| Trade name | Bosulif |
| Specification | 100mg |
| Main ingredients | Bosutinib Monohydrate |
| Dosage Form | Tablet |
| MA Holder | PF PRISM CV |
| Category | Reference Listed Drugs (RLDs) |
Indications:
Bosulif is indicated for the treatment of adult patients with:
1. newly-diagnosed chronic phase (CP) Philadelphia chromosome-positive chronic myelogenous leukaemia (Ph+ CML).
2. CP, accelerated phase (AP), and blast phase (BP) Ph+ CML previously treated with one or more tyrosine kinase inhibitor(s) [TKI(s)] and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.
For more details, pls contact Janney:
Email: tosun-global@upharm.cn
Wechat/Whatsapp:(+86)18922120575
Hot Tags: bosutinib monohydrate tablets reference listed drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Alfacalcidol Soft Capsules, Phenytoin Sodium Tablets, Acarbose Tablets, AdapaleneGel, Bimatoprost Ophthalmic, Agomelatine Tablets
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China
